"Momentum building" for UK asbestos diseases R&D hub
This article was originally published in Clinica
Executive Summary
Momentum is building behind the creation in the UK of a national R&D centre for asbestos-related diseases (NCARD), Clinica has learnt. During events and meetings held at ministerial level in the run up to Action Mesothelioma Day (February 27), ministers have been made aware of the growing magnitude of the need for more and better-co-ordinated R&D.